New on Netcapital: DeoBio Sciences

Click to rate this post!
[Total: 0 Your Rating: 0]


DeoBioSciences (DBS) is a stealth mode, R&D stage, virtual biotech developing a cancer drug, based on a naturally occurring compound, that selectively kills both early and advanced stage cancer cells from humans and, potentially, dogs and cats as well.

Deal Highlights

Major biotechs and pharmas have confirmed, in writing, their interest in pursuing in-licensing or partnerships, upon the presentation of more positive data
Cornell University’s top scientists, among others, are anxious to continue working with us to take our research to the next level
Their stealth tech has other potential applications that we will pursue to maximize our chances of success


Join Our Newsletter



By Registering, you agree that you've read and accepted our disclaimer, you're at least 18 years old, you consent to the terms presented on the disclaimer, and to receive notifications from us.